Mestag Therapeutics extends seed financing to $45 million backed by Forbion, GV and Northpond Ventures

Biotech Health services Manufacturing

Investments

01 August 2021

Mestag Therapeutics (company)

Biotech Health services Manufacturing

Total investments received (USD): 96m

Round value (USD): 45m

Round investors: Forbion Capital Partners GV Northpond Ventures

Industry: Biotech Health services Manufacturing

Biotech Health services

Investments 31 January 2022

Biotech Manufacturing

Investments 30 January 2022

AI (big data) Biotech Health services Software Services

Investments 07 December 2021

Biotech Health services Software Services

Investments 15 November 2021

Hardware Health services Manufacturing Software Services

Investments 07 November 2021